Cargando…

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

BACKGROUND: Among locally advanced gastric cancer (LAGC) patients, poor response to initial neoadjuvant chemotherapy (NAC) is associated with unfavorable outcomes; however, changing the postoperative therapy regimen in this group of patients is unclear. We compared the poor responders who continued...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zining, Wang, Yinkui, Shan, Fei, Ying, Xiangji, Zhang, Yan, Li, Shuangxi, Jia, Yongning, Miao, Rulin, Xue, Kan, Li, Zhemin, Li, Ziyu, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591025/ https://www.ncbi.nlm.nih.gov/pubmed/34327603 http://dx.doi.org/10.1245/s10434-021-10087-x

Ejemplares similares

Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
por: Liu, Zining, et al.
Publicado: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis
por: Li, Ziyu, et al.
Publicado: (2018)

Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial
por: Li, Ziyu, et al.
Publicado: (2018)

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study
por: Wang, Yinkui, et al.
Publicado: (2022)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials
por: Lei, Xiaokang, et al.
Publicado: (2022)

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
por: Li, Ziyu, et al.
Publicado: (2020)

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients
por: Li, Ziyu, et al.
Publicado: (2016)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Wu, Zhouqiao, et al.
Publicado: (2021)

Prognostic Significance of Lymphatic, Venous and Perineural Invasion After Neoadjuvant Chemotherapy in Patients with Gastric Adenocarcinoma
por: Woodham, Benjamin L., et al.
Publicado: (2020)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
por: Kano, Masayuki, et al.
Publicado: (2019)

Predicting peritoneal carcinomatosis of gastric cancer: A simple model to exempt low-risk patients from unnecessary staging laparoscopy
por: Li, Zhemin, et al.
Publicado: (2022)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer
por: Miao, Ying, et al.
Publicado: (2022)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Analysis of the Survival Impact of Postoperative Chemotherapy After Preoperative Chemotherapy and Resection for Gastric Cancer
por: Drake, Justin A., et al.
Publicado: (2020)

Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial
por: Li, Ziyu, et al.
Publicado: (2018)

Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes
por: Kusano, Toru, et al.
Publicado: (2013)

MRI for the evaluation of gastric physiology
por: de Zwart, Ingrid M., et al.
Publicado: (2010)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

Gastric outlet obstruction in the setting of acute cholecystitis
por: Uko, Imo I., et al.
Publicado: (2020)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Massive Gastric Distension from Chronic Intestinal Pseudo-Obstruction
por: DeNazareth, Andrew G, et al.
Publicado: (2012)

Giant hepatic cyst as a cause of gastric outlet obstruction
por: Day, Ryan J., et al.
Publicado: (2019)

Intramural gastric air in an acutely ill patient with endoscopic and surgical correlation
por: Athanasiou, Sofia, et al.
Publicado: (2020)

Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM)
por: Mazzei, Maria Antonietta, et al.
Publicado: (2021)

Rare mesenchymal antral gastric tumors: Case reports of glomus tumor and plexiform fibromyxoma
por: Vieites Branco, Inês, et al.
Publicado: (2019)

A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma
por: Liu, Zining, et al.
Publicado: (2022)

Laparoscopic adjustable gastric band erosion with intragastric band migration: A rare but serious complication
por: Hota, Partha, et al.
Publicado: (2017)

Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World Study
por: Zhao, Lulu, et al.
Publicado: (2023)

New coil concept for endoluminal MR imaging: Initial results in staging of gastric carcinoma in correlation with Histopathology
por: Heye, Tobias, et al.
Publicado: (2006)

Gastric cancer and imaging biomarkers: Part 1 – a critical review of DW-MRI and CE-MDCT findings
por: Giganti, Francesco, et al.
Publicado: (2018)

Omental herniation through the esophageal hiatus: A rare cause of gastric outlet obstruction and its CT findings
por: Tanaka, Yoshikazu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uam9bhthk1v05jtlkchel36jd3